Engineers Gate Manager LP Enzo Biochem Inc Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$3.01 - $4.0 $47,503 - $63,128
-15,782 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$2.79 - $4.31 $23,502 - $36,307
-8,424 Reduced 34.8%
15,782 $53,000
Q1 2019

May 15, 2019
BUY
$2.54 - $4.02 $13,248 - $20,968
5,216 Added 27.47%
24,206 $66,000
Q4 2018

Feb 14, 2019
BUY
$2.46 - $4.2 $6,031 - $10,298
2,452 Added 14.83%
18,990 $53,000
Q3 2018

Nov 01, 2018
SELL
$3.81 - $5.53 $1,280 - $1,858
-336 Reduced 1.99%
16,538 $68,000
Q2 2018

Aug 03, 2018
BUY
$5.06 - $6.78 $85,382 - $114,405
16,874 New
16,874 $88,000

Others Institutions Holding ENZ

# of Institutions
48
Shares Held
15.5M
Call Options Held
2.3K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $33.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email